Diferencia entre revisiones de «Anticoagulants»
(Created page with "==Vitamin K Antagonist== ''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C...") |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
[[File:Anticoagulants.png|thumb]] | |||
==Vitamin K Antagonist== | ==Vitamin K Antagonist== | ||
''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S'' | ''Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S'' | ||
| Línea 23: | Línea 25: | ||
*[[Bivalirudin]] | *[[Bivalirudin]] | ||
==See Also== | ==See Also== | ||
*[[Anticoagulant reversal for life-threatening bleeds]] | *[[Anticoagulant reversal for life-threatening bleeds]] | ||
*[[Antiplatelet medications]] | *[[Antiplatelet medications]] | ||
Revisión del 22:42 12 nov 2016
Vitamin K Antagonist
Blocks activation of vitamin K dependent prothrombotic factors II, VII, IX, X and blocks synthesis of vitamin K dependent ANTI-thrombotic proteins C and S
Heparins
Bind to and activate antithrombin, which in turns inactivates factor Xa and thrombin
Factor Xa Inhibitors
Inhibits Factor Xa, leading to inactivation of thrombin
- Rivaroxaban (Xarelto)
- Apixaban (Eliquis)
- Fondaparinux
- Edoxaban
Direct Thrombin Inhibitors
Self-explanatory